Baird Medical Investment Holdings Limited(BDMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 5 at 7:07 AM ET (Korea 11/5 21:07)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.55 | Insider Own | 80.99% | Shs Outstand | 7.3M | Perf Week | -56.36% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 6.1M | Perf Month | -86.01% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | 0.08 | Inst Own | 1.33% | Short Float | 0.37% | Perf Quarter | -90.75% |
| Income | -0.02B | P/S | 0.14 | EPS this Y | - | Inst Trans | 13.16% | Short Ratio | 0.01 | Perf Half Y | -93.87% |
| Sales | 0.02B | P/B | 0.1 | EPS next 5Y | - | ROA | -21.15% | Short Interest | 0.02M | Perf YTD | -91.98% |
| Book/sh | 1.09 | P/C | 12.03 | EPS past 3/5Y | - -152.36% | ROE | -45.33% | 52W High | -97.05% ($3.70) | Perf Year | -90.98% |
| Cash/sh | 0.01 | P/FCF | 0.81 | Sales past 3/5Y | - | ROIC | -40.79% | 52W Low | 50.48% ($0.07) | Perf 3Y | -98.98% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -0.88% | Gross Margin | 85.63% | Volatility(W/M) | 79.55% 36.12% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.88 | Sales Y/Y TTM | - | Oper. Margin | -58.52% | ATR (14) | 0.09 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.26 | EPS Q/Q | 36.52% | Profit Margin | -65.12% | RSI (14) | 12.77 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.29 | Sales Q/Q | - | SMA20 | -74.85% ($0.44) | Beta | -0.96 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.53 | Earnings | 2026/9/3 | SMA50 | -85.45% ($0.76) | Rel Volume | 1.81 | Prev Close | $0.12 |
| Employees | 146 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | - | SMA200 | -91.74% ($1.33) | Avg Volume(3M) | 3.23M | Price | $0.11 |
| IPO | 2021/12/16 | Option/Short | No/Yes | Trades | 2413 | Volume | 5,845,480 | Change | -6.75% |
A global medical device company specializing in the treatment of thyroid nodules and breast tumors through microwave ablation (MWA) technology. Leveraging its non-invasive surgical solutions, the company is expanding its market reach beyond China to the Americas and across Asia.
Over the past 1 year, on the lower side
97% below its 1-year high.
Traded more than usual. That is 181% of its average volume.
BDMD has weak earning power
Of every $100 in sales, $58.52 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $14. Peers typically go for $143.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -99.0%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 1.3%.
Tap to view numbers
It ranks #129 of 140 in the industry
Based on market cap of $3M.
XAIR#127 Beyond Air Inc $4M PER - 
VVOS#128 Vivos Therapeutics Inc $4M PER - BDMD#129 Baird Medical Investment Holdings Limited $3M PER - 
CODX#130 Co-Diagnostics Inc $3M PER - 
AMIX#131 Autonomix Medical Inc $3M PER - 
FAQ
What kind of company is BDMD?
BDMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of BDMD?
The market cap of BDMD is approximately $3M, ranking 5,697 within its sector.
What is the 52-week high and low for BDMD?
BDMD has recorded a 52-week high of $3.70 and a low of $0.07.
